Kyle Davis, MD - Pediatric Hematologist

Pediatric Hematologist-Oncologist


Get to know Dr. Davis

Dr. Davis is a board-certified Pediatric Hematologist-Oncologist at the Indiana Hemophilia and Thrombosis Center (IHTC).

Education & Training

  • Wright State University | MD
  • Nationwide Children’s Hospital | Pediatric Residency
  • Nationwide Children’s Hospital | Pediatric Hematology-Oncology Fellowship

Certifications & Licensure

  • American Board of Pediatrics

Societies & Honors

  • American Society of Hematology HONORS Award
  • Alpha Omega Alpha Honor Medical Society
  • Arnold P. Gold Humanism Honor Society
  • National Hemophilia Foundation – Thomas H. Burr Advocacy Award
  • National Hemophilia Foundation – Lifeblood Award for Inspiration
  • American Medical Association- Physicians of Tomorrow Award
  • United States Public Health Service – Excellence in Public Health Award

Expertise & Special Interests

  • Hemophilia
  • von Willebrand Disease (VWD)
  • Rare Bleeding Disorders
  • Pediatric Thrombosis
  • Clinical Research

"Working with families to address life's obstacles despite a challenging diagnosis is one of my many passions. IHTC is the right place for children to grow up learning about their condition and how to live life to the fullest."


Screening urinalysis demonstrates that haematuria is a frequent finding in persons with haemophilia treated at a paediatric haemophilia treatment centre. Haemophilia. Jul 10;25(5): 782-8. 2019. Davis, KA, Stanek, JR, & Dunn, AL.

Use of cardiac MRI to assess antitumor efficacy of Everolimus in sporadic cardiac rhabdomyoma. Pediatrics. May 14;146(6):e20182495. 2019. Davis, KA, Dodeja, AK, Clark, A, Hor, K, Baker, P, Cripe, LH, Cripe, TP.

Light transmission aggregometry does not correlate with the severity of δ-granule platelet storage pool deficiency. J Pediatr Hematol Oncol. Oct;38(7):525-528. 2016. Woods, GM, Kudron, EL, Davis, K, Stanek, J, Kerlin, BA, O’Brien, SH.

A short interview with Kyle Davis, MD - Pediatric Hematologist

What do you like about IHTC and its approach to care?

IHTC provides model care for people with bleeding, clotting and other blood disorders. Our comprehensive approach ensures patients and their families are fully supported in their medical care.

How would you describe your approach to patient care?

I approach patient care from an educational perspective. Both of my parents are in education and my goal with each visit is to help patients and their families understand their medical condition and provide them with the support they need to make the best medical decisions possible.

What aspects of your work are you the most passionate about?

I am most passionate about patient advocacy. I feel strongly that our patients should have access to stable healthcare, the latest treatments and research opportunities to offer improved care for future generations.